Faia KL - Search Results

1

IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.

Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. Fitzgerald KA, et al. Among authors: faia kl. Nat Immunol. 2003 May;4(5):491-6. doi: 10.1038/ni921. Nat Immunol. 2003. PMID: 12692549

2

Chemokines and their receptors in allograft rejection.

Hancock WW, Gao W, Faia KL, Csizmadia V. Hancock WW, et al. Among authors: faia kl. Curr Opin Immunol. 2000 Oct;12(5):511-6. doi: 10.1016/s0952-7915(00)00130-8. Curr Opin Immunol. 2000. PMID: 11007352 Review.

3

Requirement of the chemokine receptor CXCR3 for acute allograft rejection.

Hancock WW, Lu B, Gao W, Csizmadia V, Faia K, King JA, Smiley ST, Ling M, Gerard NP, Gerard C. Hancock WW, et al. J Exp Med. 2000 Nov 20;192(10):1515-20. doi: 10.1084/jem.192.10.1515. J Exp Med. 2000. PMID: 11085753 Free PMC article.

4

Donor-derived IP-10 initiates development of acute allograft rejection.

Hancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N, Luster AD. Hancock WW, et al. Among authors: faia kl. J Exp Med. 2001 Apr 16;193(8):975-80. doi: 10.1084/jem.193.8.975. J Exp Med. 2001. PMID: 11304558 Free PMC article.

5

Beneficial effects of targeting CCR5 in allograft recipients.

Gao W, Faia KL, Csizmadia V, Smiley ST, Soler D, King JA, Danoff TM, Hancock WW. Gao W, et al. Among authors: faia kl. Transplantation. 2001 Oct 15;72(7):1199-205. doi: 10.1097/00007890-200110150-00003. Transplantation. 2001. PMID: 11602842

6

Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.

Haskell CA, Hancock WW, Salant DJ, Gao W, Csizmadia V, Peters W, Faia K, Fituri O, Rottman JB, Charo IF. Haskell CA, et al. J Clin Invest. 2001 Sep;108(5):679-88. doi: 10.1172/JCI12976. J Clin Invest. 2001. PMID: 11544273 Free PMC article.

7

Impact of the Smoothened inhibitor, IPI-926, on smoothened ciliary localization and Hedgehog pathway activity.

Peluso MO, Campbell VT, Harari JA, Tibbitts TT, Proctor JL, Whitebread N, Conley JM, White KF, Kutok JL, Read MA, McGovern K, Faia KL. Peluso MO, et al. Among authors: faia kl. PLoS One. 2014 Mar 7;9(3):e90534. doi: 10.1371/journal.pone.0090534. eCollection 2014. PLoS One. 2014. PMID: 24608250 Free PMC article.

8

PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models.

Winkler DG, Faia KL, DiNitto JP, Ali JA, White KF, Brophy EE, Pink MM, Proctor JL, Lussier J, Martin CM, Hoyt JG, Tillotson B, Murphy EL, Lim AR, Thomas BD, Macdougall JR, Ren P, Liu Y, Li LS, Jessen KA, Fritz CC, Dunbar JL, Porter JR, Rommel C, Palombella VJ, Changelian PS, Kutok JL. Winkler DG, et al. Among authors: faia kl. Chem Biol. 2013 Nov 21;20(11):1364-74. doi: 10.1016/j.chembiol.2013.09.017. Epub 2013 Nov 7. Chem Biol. 2013. PMID: 24211136

9

The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies.

Faia K, White K, Murphy E, Proctor J, Pink M, Kosmider N, McGovern K, Kutok J. Faia K, et al. PLoS One. 2018 Aug 1;13(8):e0200725. doi: 10.1371/journal.pone.0200725. eCollection 2018. PLoS One. 2018. PMID: 30067771 Free PMC article.

10

Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists.

Tremblay MR, Nevalainen M, Nair SJ, Porter JR, Castro AC, Behnke ML, Yu LC, Hagel M, White K, Faia K, Grenier L, Campbell MJ, Cushing J, Woodward CN, Hoyt J, Foley MA, Read MA, Sydor JR, Tong JK, Palombella VJ, McGovern K, Adams J. Tremblay MR, et al. J Med Chem. 2008 Nov 13;51(21):6646-9. doi: 10.1021/jm8008508. Epub 2008 Oct 9. J Med Chem. 2008. PMID: 18842035

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page